Research

For over twenty years, InterHealth set the standard for research on nutritional ingredients. We conduct comprehensive independent safety and efficacy studies at leading universities that are published in peer reviewed journals.

Home : Research Overview : UC-II Clinically Proven More Effective than GC

UC-II® Clinically Proven More than Twice as Effective than Glucosamine + Chondroitin in a Randomized Double-Blind Study Published in a Peer Reviewed Journal


arrow  Back to Research

In a randomized, double-blind, clinical study 40 mg of UC-II was more than two-times as effective as 1,500 mg of glucosamine + 1,200 mg of chondroitin in promoting complete joint health. It outperformed the glucosamine/chondroitin combination using three different assessment tools: WOMAC, VAS, and Lequesne functional index.

·          Reduced WOMAC score by 33% compared to 14% with glucosamine + chondroitin
·          Reduced VAS score by 40% compared to 15% with glucosamine + chondroitin
·          Reduced Lequesne score by 20% compared to 6% with glucosamine + chondroitin

UC-II was also shown to improve quality of life. UC-II significantly decreased pain during daily activities, including walking on a flat surface, performing heavy domestic duties, ascending stairs and while resting in bed. This is an extremely important benefit as every day activities can become difficult tasks for people who suffer from osteoarthritis. UC-II was also shown to be safe and well-tolerated with no known side effects.

Source: Crowley DC, Lau FC, Sharma P, et al. Safety and efficacy of undenatured type II collagen in the treatment of osteoarthritis of the knee: a clinical trial. Int J Med Sci. 2009;6:312-321.
 


arrow  Back to Research

InterHealth Ingredients

Go